Anti-fibrotic agents are therapeutic compounds designed to prevent or reduce the formation of fibrosis, which is the excessive accumulation of extracellular matrix (ECM) components, leading to tissue scarring and impaired organ function. Fibrosis can affect various organs, including the liver, lungs, kidneys, and heart. These agents have become a focal point in histological studies due to their potential to mitigate the adverse effects of chronic diseases.
